Microbot Medical (MBOT) vs Spectral AI (MDAI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Spectral AI (MDAI) has outperformed Microbot Medical (MBOT) over the past year, losing 35.2% versus a loss of 65.3%. Over five years, MDAI leads with a -83.2% price change compared with -84.4% for MBOT. Microbot Medical is the larger company by market cap ($71.9 million vs $52.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBOT | MDAI |
|---|---|---|
| Share price | $1.07 | $1.64 |
| Market cap | $71.87M | $52.78M |
| 1-day change | -4.46% | 0.00% |
| YTD return | -44.00% | +15.49% |
| 1-year return | -65.33% | -35.18% |
| 5-year return | -84.38% | -83.20% |
| EPS (TTM) | $-0.25 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.17 | $2.97 |
| 52-week low | $1.05 | $1.18 |
| Distance from 52-week high | -66.25% | -44.78% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +491.59% | +211.59% |
| Average volume | 649.10K | 150.48K |
| Shares outstanding | 67.16M | 32.18M |
| Employees | 43 | 65 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MDAI has outperformed MBOT by 30.1 percentage points over the past year.
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Healthcare · Medical Devices · 43 employees
About Spectral AI
MDAI stock →Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Healthcare · Medical Devices · 65 employees
MBOT vs MDAI FAQ
Which is bigger, Microbot Medical or Spectral AI?
Microbot Medical (MBOT) is larger, with a market capitalization of $71.87M compared with $52.78M for Spectral AI (MDAI).
Which stock has performed better over the past year, MBOT or MDAI?
MDAI returned -35.18% over the past 12 months, compared with -65.33% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are Microbot Medical and Spectral AI in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.